Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.2%

4 terminated/withdrawn out of 185 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

9%

17 trials in Phase 3/4

Results Transparency

0%

0 of 32 completed trials have results

Key Signals

41 recruiting

Enrollment Performance

Analytics

N/A
72(64.9%)
Phase 2
16(14.4%)
Phase 4
11(9.9%)
Phase 3
6(5.4%)
Phase 1
6(5.4%)
111Total
N/A(72)
Phase 2(16)
Phase 4(11)
Phase 3(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (185)

Showing 20 of 185 trials
NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT06538883Not ApplicableRecruiting

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT07073430Recruiting

Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions

Role: lead

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07354295Recruiting

Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)

Role: collaborator

NCT06696820Phase 2Recruiting

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07053137Active Not Recruiting

A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

Role: collaborator

NCT07031674Completed

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Role: collaborator

NCT07069972Not Yet Recruiting

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Role: collaborator

NCT05300932Phase 4Active Not Recruiting

A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis

Role: collaborator

NCT07368309Completed

Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer

Role: lead

NCT07361783Not ApplicableRecruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

Role: collaborator

NCT05868915Phase 1Terminated

HV-101 for Patients With Advanced Solid Tumors

Role: collaborator

NCT07302009Not ApplicableNot Yet Recruiting

Targeted Temperature Management Via Bladder Monitoring in ICH

Role: collaborator

NCT06518655Recruiting

Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

Role: collaborator

NCT07294027Not ApplicableNot Yet Recruiting

ICSI Versus Conventional IVF in Couples With Unexplained Infertility

Role: collaborator

NCT07085533Recruiting

Natural History Study of Inherited Retinal Diseases

Role: collaborator

NCT07269509Not ApplicableNot Yet Recruiting

Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial

Role: lead